Teuku Zulfahmi Rizki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Teuku Zulfahmi Rizki has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Lilies Dwi Sulistyani
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Universitas Indonesia, Jakarta, 10430, Indonesia
2 shared publications - Vera Julia
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Universitas Indonesia, Jakarta, Indonesia
2 shared publications - Arfan Badeges
Department of Oral and Maxillofacial Surgery, Persahabatan Central General Hospital, Jakarta, Indonesia
1 shared publication - Budi Haryanto
Department of Clinical Microbiology, Persahabatan National Respiratory Referral Hospital, Jakarta, Indonesia., Indonesia
1 shared publication - Dwi Ariawan
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Universitas Indonesia, Jakarta, Indonesia
1 shared publication - Dwi Kasta Dharmawan
Universitas Indonesia, Indonesia
1 shared publication
Latest Publications
- Open Access
- 30 April 2025
- Published by Wroclaw Medical University in Dental and Medical Problems
- Vol. 62 (2) , 217-223
Effects of chlorhexidine gluconate and povidone-iodine mouthwash on cycle threshold values in patients infected with SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants exhibit different phenotypes and clinical manifestations in comparison to non-mutated viruses. Spike gene target failure (SGTF) is a characteristic feature of the gene in a novel variant that is recognized as highly transmissible. Several studies have demonstrated the virucidal effects of mouthwashes on SARS-CoV-2. Moreover, mouthwashes have proven beneficial for patients undergoing oral and maxillofacial surgery. The present study aimed to analyze the effects of 2 different types of mouthwash (0.2% chlorhexidine gluconate and 1% povidone-iodine) on the cycle threshold (CT) values in coronavirus disease 2019 (COVID-19) patients with and without SGTF. This single-blind, non-randomized controlled clinical trial comprised 45 patients who were divided into 3 groups based on the intervention method: 0.2% chlorhexidine gluconate mouthwash; 1% povidone-iodine mouthwash; and mineral water (control group). The patients were instructed to gargle with the assigned solution 3 times a day for 5 days. Reverse transcription polymerase chain reaction (RT-PCR) tests were conducted at the time of initial diagnosis and on days 3 and 5. A normality test (Shapiro-Wilk test) was performed. Consequently, the non-parametric Friedman test was used. The analysis revealed that the subjects who utilized mouthwashes exhibited higher CT values in comparison to the control group. Furthermore, 73% of patients who used 0.2% chlorhexidine gluconate presented with increased CT values, as indicated by a negative RT-PCR test on the 3rd day. Gargling with 0.2% chlorhexidine gluconate or 1% povidone-iodine for 30 s for at least 3 days has been demonstrated to increase CT values in both SGTF and non-SGTF COVID-19 patients. Hence, using the mouthwash may be considered for preoperative use in patients undergoing oral and maxillofacial surgery.
- 30 April 2025
- Published by Wroclaw Medical University in Dental and Medical Problems
- Vol. 62 (2) , 217-223
Open AccessEffects of chlorhexidine gluconate and povidone-iodine mouthwash on cycle threshold values in patients infected with SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants exhibit different phenotypes and clinical manifestations in comparison to non-mutated viruses. Spike gene target failure (SGTF) is a characteristic feature of the gene in a novel variant that is recognized as highly transmissible. Several studies have demonstrated the virucidal effects of mouthwashes on SARS-CoV-2. Moreover, mouthwashes have proven beneficial for patients undergoing oral and maxillofacial surgery. The present study aimed to analyze the effects of 2 different types of mouthwash (0.2% chlorhexidine gluconate and 1% povidone-iodine) on the cycle threshold (CT) values in coronavirus disease 2019 (COVID-19) patients with and without SGTF. This single-blind, non-randomized controlled clinical trial comprised 45 patients who were divided into 3 groups based on the intervention method: 0.2% chlorhexidine gluconate mouthwash; 1% povidone-iodine mouthwash; and mineral water (control group). The patients were instructed to gargle with the assigned solution 3 times a day for 5 days. Reverse transcription polymerase chain reaction (RT-PCR) tests were conducted at the time of initial diagnosis and on days 3 and 5. A normality test (Shapiro-Wilk test) was performed. Consequently, the non-parametric Friedman test was used. The analysis revealed that the subjects who utilized mouthwashes exhibited higher CT values in comparison to the control group. Furthermore, 73% of patients who used 0.2% chlorhexidine gluconate presented with increased CT values, as indicated by a negative RT-PCR test on the 3rd day. Gargling with 0.2% chlorhexidine gluconate or 1% povidone-iodine for 30 s for at least 3 days has been demonstrated to increase CT values in both SGTF and non-SGTF COVID-19 patients. Hence, using the mouthwash may be considered for preoperative use in patients undergoing oral and maxillofacial surgery.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Pesquisa Brasileira em Odontopediatria e Clínica Integrada
- Vol. 23, e220029
Donor Site Morbidity of Nonvascularized Bone Graft: A Systematic Review
To evaluate the donor site morbidity of iliac and fibular nonvascularized bone graft after mandibular resection.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Pesquisa Brasileira em Odontopediatria e Clínica Integrada
- Vol. 23, e220029
Open AccessDonor Site Morbidity of Nonvascularized Bone Graft: A Systematic Review
To evaluate the donor site morbidity of iliac and fibular nonvascularized bone graft after mandibular resection.